Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19 - A Randomized Clinical Trial

This double-blind RCT (n=476) found a 5-day course of ivermectin did not improve time to resolution of symptoms in adults with mild Covid-19 (median 10 days [IQR 9-13] versus 12 days [9-13] with placebo; HR 1.07; 95% CI 0.87-1.32; p=0.53).

Journal of the American Medical Association